Review of patients with hepatosteatosis and chronic hepatitis C.
We analysed a HCV RNA positive population with varied steatosis index admitted at Infectious Diseases and Hepatology Department, Medical University of Wroclaw in terms of existing abnormalities in biochemistry parameters, anthropometric differences as well as the antiviral therapy outcomes.
Smoliński
Patryk
P
Katedra i Klinika Chorób Zakaźnych, Chorób Watroby i Nabytych Niedoborów Odpornościowych Akademii Medycznej we Wrocławiu. psmolinski@poczta.onet.pl
Pazgan-Simon
Monika
M
Zuwała-Jagiełło
Jolanta
J
Hałoń
Agnieszka
A
Rotter
Katarzyna
K
Gładysz
Andrzej
A
D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D015992:Body Mass Index; D005234:Fatty Liver / Q000097:blood / Q000188:drug therapy / Q000473:pathology* / Q000821:virology*; D005260:Female; D005355:Fibrosis; D016174:Hepacivirus / Q000302:isolation & purification*; D019698:Hepatitis C, Chronic / Q000097:blood / Q000188:drug therapy / Q000473:pathology* / Q000821:virology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011044:Poland; D012367:RNA, Viral / Q000097:blood; D012307:Risk Factors
D000998:Antiviral Agents; D012367:RNA, Viral